A. Peter Thompson

Affiliations

  • Large Shareholder, Director at Edgewise Therapeutics Inc. (EWTX), 2024-01-25
  • Director at Alpine Immune Sciences Inc. (ALPN), 2024-01-16
  • at Corvus Pharmaceuticals Inc. (CRVS), 2023-12-08
  • Director at Ars Pharmaceuticals Inc. (SPRY), 2023-08-31
  • Large Shareholder, Director at Decibel Therapeutics Inc. (DBTX), 2022-06-21
  • Director at Janux Therapeutics Inc. (JANX), 2022-06-16
  • Large Shareholder, Director at Pmv Pharmaceuticals Inc. (PMVP), 2021-06-09
  • Large Shareholder, Director at Prevail Therapeutics Inc. (PRVL), 2021-01-26
  • Large Shareholder, Director at Synthorx Inc. (THOR), 2020-01-24
  • Director at Principia Biopharma Inc. (PRNB), 2018-09-13
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2018-06-06
  • Large Shareholder, Director at Response Biomedical Corp (RBM), 2016-12-02
  • Director at Pronai Therapeutics Inc (DNAI), 2015-07-21
  • Director at Mirati Therapeutics Inc. (MRTX), 2013-07-12
  • Director at Anthera Pharmaceuticals Inc (ANTH), 2012-05-11
  • Officer, Director at Trubion Pharmaceuticals Inc (TRBN), 2009-05-26
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EWTX $11.00 454,545 Large Shareholder, Director 14,436,497 2024-01-23 Filing
SPRY $6.20 500,000 Director 8,019,187 2023-08-29 Filing
EWTX $10.32 484,496 Large Shareholder, Director 13,981,952 2022-09-16 Filing
EWTX $7.21 138,000 Large Shareholder, Director 13,497,456 2022-05-18 Filing
ALPN $9.40 425,531 Large Shareholder, Director 425,531 2021-09-17 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALPN $18.32 139,166 Director 264,315 2023-12-28 Filing
ALPN $18.32 1,195,683 Director 2,270,930 2023-12-28 Filing
ALPN $19.82 3,128 Director 403,481 2023-12-28 Filing
ALPN $19.82 26,872 Director 3,466,613 2023-12-28 Filing
ALPN $19.96 18,922 Director 406,609 2023-12-27 Filing